Clinical Laboratory Testing Volume 1: Reagents and Instruments

Product Code TRI00089
Publication Date September 2010
Publisher TriMark Publications
Product Type Report
Pages 308
ISBN Number not applicable
Change currency
PDF £2,150.00 €2,589 $3,400 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Clinical Laboratory Testing Volume 1: Reagents and Instruments

Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large market employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this TriMark Publications report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this global clinical laboratory markets report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers’ original equipment manufacturer (OEM) additional equipment. The emphasis in this analysis is on those companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician’s offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. The regional markets and their differences are examined, including Europe, Asia (Japan, China and India) and the rest of the world (ROW). Particular attention is paid to those areas of the clinical laboratory instrumentation and reagents sector that are showing the greatest growth or the most innovation.

Contents

  • 1. Overview
    • 1.1 Objectives of the Report
    • 1.2 Methodology
    • 1.3 Scope of the Report
    • 1.4 Executive Summary
  • 2. IVD Clinical Laboratory Market
    • 2.1 Introduction
    • 2.2 Independent Clinical Labs
    • 2.2.1 Key Players for Independent Clinical Labs
    • 2.2.2 Quest Diagnostics and LabCorp
    • 2.2.3 Competitive Advantages at Quest and LabCorp
    • 2.2.4 Revenue Growth of Quest and LabCorp
    • 2.2.5 Sector Consolidation
    • 2.2.6 Additional Independent Clinical Laboratories
    • 2.3 Hospital Market
    • 2.3.1 Hospital Market Overview
    • 2.3.2 Hospital Lab Testing Drivers
    • 2.3.3 Evaluation Models of Laboratory Testing
    • 2.3.4 GPOs and IDNs
    • 2.3.5 Distributors
    • 2.3.6 Clinical Lab Testing Suppliers
    • 2.3.7 European Hospital Purchasing Practices
    • 2.3.8 Changes in Hospital Funding
    • 2.3.9 European Group Purchasing
    • 2.4 POL Market
    • 2.5 IVD Industry
    • 2.5.1 Industry Overview
    • 2.5.2 IVD Industry Leading Players Comparison and Review
    • 2.5.2.1 Roche Diagnostics
    • 2.5.2.2 Abbott Laboratories
    • 2.5.2.3 Siemens Healthcare Diagnostics
    • 2.5.2.4 Becton, Dickinson & Co
    • 2.5.2.5 Beckman Coulter, Inc
    • 2.5.2.6 Ortho-Clinical Diagnostics
    • 2.5.2.7 bioMerieux
    • 2.5.2.8 Sysmex
    • 2.5.2.9 Bio-Rad Laboratories, Inc
    • 2.5.2.10 ARKAY, Inc
    • 2.5.2.11 Cytyc Corporation (A Hologic Company)
    • 2.5.2.12 Gen-Probe, Inc
    • 2.5.3 Biotechnology Reagents and Supplies
    • 2.5.3.1 Vendor Quality Assurance
    • 2.5.3.2 Partnership Support
    • 2.5.3.3 Protecting Supply of Raw Materials
    • 2.5.3.4 Selecting a Second Source for Chemicals
    • 2.5.3.5 Cost Analysis for Reagent Manufacture
    • 2.5.3.6 Outsourcing Production of Reagents
    • 2.5.4 The Fastest Growing IVD Reagent Markets
    • 2.5.5 High Growth Applications Spur Industry Growth
    • 2.6 Automated Instrument Platforms Evolution
    • 2.7 Reagents and Supplies Market for Clinical Lab Instruments
    • 2.8 Spending for Clinical Laboratory Testing
    • 2.8.1 Reimbursement Pressure
    • 2.8.2 Medicare Part B Spending Trends
    • 2.8.3 Strategies for Revenue Growth
    • 2.8.4 Electronic Health Records
  • 3. IVD Clinical Laboratory Market
    • 3.1 Markets
    • 3.1.1 Global Markets
    • 3.1.2 Global Drivers of Clinical Laboratory Testing
    • 3.1.3 Global Outlook
    • 3.1.4 U.S. Market
    • 3.1.5 European IVD Market
    • 3.1.5.1 German Clinical Laboratory Diagnostic Markets
    • 3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Market
    • 3.1.5.2.1 U.K. Competitive Analysis
    • 3.1.5.2.2 U.K. Market Access
    • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
    • 3.1.5.4 Italian Clinical Laboratory Diagnostic Market
    • 3.1.5.5 Spanish Clinical Laboratory Diagnostic Market
    • 3.1.5.6 Finnish Clinical Laboratory Market
    • 3.1.5.7 Turkish Clinical Laboratory Market
    • 3.1.5.8 Belgium Clinical Laboratory Diagnostic Market
    • 3.1.5.9 Swiss Clinical Laboratory Diagnostic Market
    • 3.1.5.10 Dutch Clinical Laboratory Diagnostic Market
    • 3.1.5.11 Portuguese Clinical Laboratory Diagnostic Market
    • 3.1.5.12 Austrian Clinical Laboratory Diagnostic Market
    • 3.1.5.13 Greek Clinical Laboratory Diagnostic Market
    • 3.1.5.14 Polish Clinical Laboratory Diagnostic Market
    • 3.1.5.15 Romanian Clinical Laboratory Diagnostic Market
    • 3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Market
    • 3.1.5.17 Swedish Clinical Laboratory Diagnostic Market
    • 3.1.5.18 Norwegian Clinical Laboratory Diagnostic Market
    • 3.1.5.19 Irish Clinical Laboratory Diagnostic Market
    • 3.1.5.20 Hungarian Clinical Laboratory Diagnostic Market
    • 3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Market
    • 3.1.5.22 Slovakian Clinical Laboratory Diagnostic Market
    • 3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Market
    • 3.1.5.24 Latvian Clinical Laboratory Diagnostic Market
    • 3.1.5.25 Estonian Clinical Laboratory Diagnostic Market
    • 3.1.5.26 Slovenian Clinical Laboratory Diagnostic Market
    • 3.1.5.27 Russian Clinical Laboratory Diagnostic Market
    • 3.1.6 Asian Markets
    • 3.1.6.1 Indian Clinical Laboratory Diagnostic Market
    • 3.1.6.1.1 Indian IVD Testing Industry
    • 3.1.6.2 Japanese Clinical Laboratory Testing Market
    • 3.1.6.3 Chinese Clinical Laboratory Market
    • 3.1.7 Clinical Laboratory Smaller Country Markets
    • 3.1.7.1 Canadian Clinical Laboratory Market
    • 3.1.7.2 Brazilian Clinical Laboratory Market
    • 3.1.7.3 Australian Clinical Laboratory Market
    • 3.1.8 ROW Clinical Laboratory Testing Market
    • 3.1.9 Overview of Asian Clinical Laboratory Market
    • 3.1.9.1 Singapore
    • 3.1.9.2 Malaysia
    • 3.1.9.3 Thailand
    • 3.1.9.4 Indonesia
    • 3.1.9.5 Philippines
    • 3.1.9.6 South Korea
    • 3.1.9.7 India
    • 3.1.9.8 Hong Kong
    • 3.1.9.9 Taiwan
    • 3.1.10 Overview of the Latin American Diagnostics Market
    • 3.2 Clinical Laboratory Sector
    • 3.2.1 Industry Players
    • 3.2.2 Market Specialization
    • 3.2.3 Revenue and Reimbursement
    • 3.2.4 Companies
    • 3.3 Outlook for Clinical Laboratory Testing
    • 3.3.1 Long-term Changes
    • 3.3.2 Market Drivers
    • 3.3.3 The Limits to Growth
    • 3.3.4 Hot Sectors in the IVD Market
    • 3.3.5 Key Technologies
    • 3.3.6 Conclusion
  • 4. Clinical Laboratory Instrument Market by Sector
    • 4.1 Chemistry Analyzers
    • 4.1.1 Ultra-Large Throughput Laboratory Analyzers
    • 4.1.2 Large-Throughput Analyzers
    • 4.1.3 Mid-size Clinical Laboratory Analyzers
    • 4.1.4 Laboratory Analyzers for the Small Volume Market
    • 4.2 Immunochemistry Analyzers
    • 4.2.1 Large Immunochemistry Analyzers
    • 4.2.2 Small Immunoassay Analyzers
    • 4.3 Hematology Analyzers
    • 4.4 Point of Care Testing
    • 4.5 Cytology Testing
    • 4.6 Microbiology Testing
    • 4.7 Serology Testing
    • 4.8 Esoteric Testing
    • 4.9 Anatomic Pathology
    • 4.9.1 Histology
    • 4.9.2 IHC Staining
    • 4.9.3 ISH Staining
    • 4.9.4 Special Stains Staining
    • 4.9.5 Tissue Staining Market
    • 4.9.6 Cancer Diagnostics; Anatomic Pathology
    • 4.10 Drug Testing
  • 5. Important Technology Trends in IVD Instrumentation and Reagents
    • 5.1 Technology Innovations in Instrument and Reagent Development
    • 5.2 Sensor Systems for Diagnostic Applications
    • 5.3 Glucose Measurements
    • 5.4 Glucose Test Methods
    • 5.5 Cholesterol Measurements
    • 5.6 The New Paradigm
    • 5.7 Consolidated Workstations
    • 5.8 Automation in the Laboratory
    • 5.9 Laboratory Information Systems
    • 5.10 New User-friendly Interfaces
    • 5.11 Biosensor Technology
    • 5.12 Data-Management Issues
    • 5.12.1 Wireless LANs
    • 5.12.2 Cepheid's POC GBS and BCR/ABL Tests
    • 5.12.3 Data and Workflow Management Systems
    • 5.12.4 Beckman Central Command
  • 6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market
    • 6.1 Key Market Developments
    • 6.1.1 Decreasing Revenue from Traditional IVD Markets
    • 6.1.2 High Growth in POCT and Molecular Diagnostics Arena
    • 6.1.3 Move Away from Traditional Kit Testing Methods
    • 6.1.4 Integrated Analytical Systems
    • 6.1.5 Regulatory Changes
    • 6.1.6 Development of a Two-Tier Industry Structure
    • 6.1.7 Labor Costs
    • 6.1.8 Increasing Value of Companies with High-Margin Technology Platforms
    • 6.1.9 The Joining of IVD Testing and Computer Technology
    • 6.1.10 User-friendly User Interfaces
    • 6.2 Sector Consolidation
    • 6.2.1 IVD Company Consolidation
    • 6.2.2 Lab Company Consolidation
    • 6.2.2.1 Acquisition Pricing
    • 6.2.2.2 A Closer Look at Six Big Lab Deals
    • 6.3 Diagnostic Testing Growth Trends
    • 6.4 Reagent and Hardware Business in Japan
    • 6.5 New Products
    • 6.6 Acquisition, License Agreements, Internal Development and Partnerships
    • 6.7 Product Testing Depth in Clinical Laboratory Testing
    • 6.8 Government Regulation of IVD Devices
    • 6.8.1 U.S. Regulation
    • 6.8.1.1 Importing Medical Devices into the U.S
    • 6.8.1.2 Exporting Medical Devices from the U.S
    • 6.8.2 U.K. Regulation
    • 6.8.3 E.U. Regulation
    • 6.8.3.1 France
    • 6.8.4 Japanese Regulation
    • 6.8.5 Korean Regulation
    • 6.8.6 Chinese Regulation
    • 6.9 Increased Market Penetration
    • 6.10 Costs of Doing Business in Europe
    • 6.11 Drivers of European Diagnostics Testing
    • 6.12 European Reimbursement Practices
    • 6.13 Cost Containment in Europe
    • 6.14 Hospital Outreach Programs
    • 6.15 Electronic Procurement: New Challenges
    • 6.16 Competition for Supply Chain Management Solutions
    • 6.17 E-Commerce in the Hospital Supply Chain
    • 6.17.1 Drivers of E-Commerce Solutions
    • 6.17.2 Barriers to E-Commerce Solutions
    • 6.18 Top Trends in Laboratory Business Practices
    • 6.19 The Value of the New Diagnostics
    • 6.20 Converging Technologies-Drugs and Diagnostic Tests Combine for Improved Healthcare
    • 6.21 Emerging Technologies in the Downstream Manufacture of Bio-Materials
    • 6.22 GMP Readiness
    • 6.23 Harnessing Human Resource Capabilities and IT Prowess: Biotechnology in the
    • Future
    • 6.24 Partnering with Patient-based Organizations to Achieve Patient Health Goals
    • 6.25 Rumors of the Platform Company's Demise are Greatly Exaggerated
    • 6.26 Who's Going to Pay for It?
    • 6.27 Clinical Trials Testing
    • 6.28 Life Insurer Services
    • 6.29 Employer Services
  • 7. Company Profiles
    • 7.1 Abaxis
    • 7.2 Abbott
    • 7.3 Adaltis, Inc
    • 7.4 Alfa Wasserman, Inc. (Formerly Electro-Nucleonics, Inc. and Schiapparelli
    • Biosystems, Inc.)
    • 7.5 Becton, Dickinson & Co
    • 7.6 Beckman Coulter, Inc
    • 7.7 Bio-Reference Laboratories, Inc
    • 7.8 bioMerieux
    • 7.9 Enzo Biochem, Inc
    • 7.10 Genomic Health, Inc
    • 7.11 Hitachi
    • 7.12 Horiba Ltd
    • 7.13 JEOL Ltd
    • 7.14 LabCorp
    • 7.15 MEDTOX Scientific, Inc
    • 7.16 Monogram Biosciences, Inc
    • 7.17 Myriad Genetics, Inc
    • 7.18 Nova Biomedical
    • 7.19 Hologic, Inc
    • 7.20 Ortho-Clinical Diagnostics, a J&J Company
    • 7.21 Psychemedics Corporation
    • 7.22 Quest Diagnostics, Inc
    • 7.23 Roche Diagnostics Corp
    • 7.24 Shimadzu
    • 7.25 Sysmex Corporation
    • 7.26 Thermo Fisher Scientific, Inc
    • 7.27 Vital Scientific, NV
  • Index of Figures
    • Figure 2.1: Clinical Laboratory Testing Sector Providers
    • Figure 2.2: Unweighted Average Medicare Reimbursement for Ten Most Common POL
    • Tests, 2002 vs. 2006
    • Figure 2.3: Total Number of Non-Waived POLs, 2000-2006
    • Figure 2.4: Part B Spending on Clinical Laboratory Services, 1991-2005
    • Figure 3.1: IVD Product Demand
    • Figure 3.2: European IVD Market by Clinical Specialty
    • Figure 3.3: Chinese IVD Market, 2006-2012
    • Figure 6.1: Hospital Market Share for Outreach Programs
    • Figure 7.1: Beckman Sales Results by Type, Segment and Region, 2009
  • Index of Tables
    • Table 2.1: Total U.S. Clinical Laboratory Revenue, 2005-2015
    • Table 2.2: U.S. Clinical Laboratory Diagnostic Test Market Segments Revenue,2009
    • Table 2.3: Drivers of Clinical Lab Testing Volume
    • Table 2.4: Independent Commercial Laboratory Testing Market Sample Volume,2005-2012
    • Table 2.5: Leading U.S. Reference Laboratories Grouped by Market Capitalization
    • Table 2.6: LabCorp Comparison of Routine and Genomic and Esoteric Testing Trends
    • Table 2.7: Revenue Growth at Quest Diagnostics, 2000-2009
    • Table 2.8: Revenue Growth at LabCorp, 2000-2009
    • Table 2.9: Quest's Total Volume of Requisitions and Net Revenues from Clinical
    • Laboratory Testing
    • Table 2.10: Number of Hospital-based Clinical Laboratory Tests in the U.S.,2002-2012
    • Table 2.11: European Cardiovascular Disease Management Expenditures, 2003-2010
    • Table 2.12: The Most Frequent Laboratory Tests Offered at Physician Offices
    • Table 2.13: U.S. Doctor's Office Lab Test Dollar Volume and Growth Rates, 2009
    • Table 2.14: Worldwide Alternate Site Clinical Lab Instrument and Reagents Sales,2005-2012
    • Table 2.15: Thirteen Largest Diagnostic Companies Worldwide
    • Table 2.16: Products Marketed by Abbott in the Diagnostic Market
    • Table 2.17: Beckman Coulter Market Share in Major Diagnostic Sectors
    • Table 2.18: Prodesse's ASRs
    • Table 2.19: CMS Reimbursement for Top 25 Clinical Laboratory Procedures
    • Table 3.1: Worldwide IVD Testing Market, 2009
    • Table 3.2: Worldwide Geographic Distribution of IVD Testing, 2009
    • Table 3.3: Global Clinical Laboratory Market Sales, 1998-2012
    • Table 3.4: U.S. Clinical Laboratory Testing Market, 2003-2012
    • Table 3.5: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2009
    • Table 3.6: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2007
    • Table 3.7: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test
    • Markets, 2009
    • Table 3.8: European Clinical Laboratory Testing IVD Reagents and Instruments
    • Market, 2000-2012
    • Table 3.9: European Clinical Laboratory Diagnostic Testing Reagents and
    • Instruments Market by Analyte, 2006
    • Table 3.10: European Clinical Chemistry Testing IVD Reagents and Instruments
    • Market, 2000-2012
    • Table 3.11: European Clinical Laboratory Testing Diagnostics by Country Market,2009
    • Table 3.12: European Rapid POCT by Country Market, 2008
    • Table 3.13: European Patient Self Testing OTC Diagnostics by Country Market,2006
    • Table 3.14: German Clinical Laboratory Testing Diagnostics Products Market
    • Sales, 2003-2012
    • Table 3.15: German Clinical Diagnostic Rapid Test Market Segments, 2008
    • Table 3.16: U.K. Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.17: U.K. Clinical Diagnostic Rapid Test Market Segments
    • Table 3.18: Major U.K. IVD Manufacturers
    • Table 3.19: U.S. IVD Manufacturers Doing Business in the U.K
    • Table 3.20: Other European Companies that Manufacture IVD Products in the U.K
    • Table 3.21: French Clinical IVD Testing Diagnostics Products Market Sales,2003-2012
    • Table 3.22: French Clinical Diagnostic Rapid Test Market Segments
    • Table 3.23: Italian Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.24: Italian Clinical Diagnostic Rapid Test Market Segments
    • Table 3.25: Spanish Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.26: Spanish Clinical Diagnostic Rapid Test Market Segments, 2008
    • Table 3.27: Finnish Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.28: Turkish Clinical Laboratory Testing Market, 2000-2012
    • Table 3.29: Belgium Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.30: Belgium Clinical Reagents and Instruments Market
    • Table 3.31: Swiss Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.32: Swiss Clinical Reagents and Instruments Market
    • Table 3.33: Dutch Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.34: Dutch Clinical Reagents and Instruments Market
    • Table 3.35: Portuguese Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.36: Portuguese Clinical Reagents and Instruments Market
    • Table 3.37: Austrian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.38: Austrian Clinical Reagents and Instruments Market
    • Table 3.39: Greek Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.40: Greek Clinical Reagents and Instruments Market
    • Table 3.41: Polish Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.42: Polish Clinical Reagents and Instruments Market
    • Table 3.43: Romanian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.44: Romanian Clinical Reagents and Instruments Market
    • Table 3.45: Czech Republic Clinical Laboratory Diagnostics Products Market
    • Sales, 2004-2012
    • Table 3.46: Swedish Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.47: Norwegian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.48: Irish Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.49: Hungarian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.50: Bulgarian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.51: Slovakian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.52: Lithuanian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.53: Latvian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.54: Estonian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.55: Slovenian Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.56: Russian Clinical Laboratory Diagnostics Products Market Sales,2007-2012
    • Table 3.57: Asian Geographic Distribution of IVD Testing, 2009
    • Table 3.58: Summary of Key Business Points of the Asian Healthcare Market
    • Table 3.59: Outlook for the Asian Healthcare Market, 2010-2012
    • Table 3.60: Asian IVD Market Drivers
    • Table 3.61: Asian IVD Market Restraints
    • Table 3.62: Top Asian IVD Growth Opportunities
    • Table 3.63: Indian IVD Market for Instruments and Reagents, 2004-2012
    • Table 3.64: Number of Automated Clinical Labs in India, 2004-2012
    • Table 3.65: Indian IVD Market
    • Table 3.66: Japanese Clinical Laboratory Testing Instrument and Reagents Market,2003-2012
    • Table 3.67: Drivers of the Japanese IVD Market
    • Table 3.68: Barriers to the Japanese IVD Market
    • Table 3.69: Drivers of Growth in the Chinese Clinical Laboratory Market
    • Table 3.70: Number of Chinese Medical Institutions
    • Table 3.71: Chinese Clinical Laboratory Diagnostics Products Market Sales,2003-2012
    • Table 3.72: Chinese IVD Market, 2008
    • Table 3.73: Proportion of Medical Expenses Paid Privately
    • Table 3.74: Market Share of Reagent Imports into the Chinese Clinical Lab Market by Country of Origin
    • Table 3.75: Analytical Instrument Imports into the Chinese Clinical Lab Market by Country of Origin
    • Table 3.76: Chinese International IVD Manufacturers
    • Table 3.77: Chinese Domestic IVD Manufacturers
    • Table 3.78: Chinese IVD Distributors
    • Table 3.79: Canadian Clinical Laboratory Testing Market, 2000-2009
    • Table 3.80: Brazilian Clinical Laboratory Testing Market, 2000-2009
    • Table 3.81: Australian Clinical Laboratory Testing Market, 2000-2009
    • Table 3.82: ROW Clinical Laboratory Testing Market, 2000-2009
    • Table 3.83: Latin American Geographic Distribution of IVD Testing, 2009
    • Table 3.84: Number of Clinical Laboratories in Latin America
    • Table 3.85: Principal Marketers of Automated Clinical Laboratory Instruments
    • Table 3.86: Key Market Drivers of Automated Clinical Laboratory Instruments
    • Table 3.87: Key Market Limits of Automated Clinical Laboratory Instruments
    • Table 4.1: Ultra-Large Clinical Laboratory Analyzers
    • Table 4.2: JEOL Analyzer Comparison
    • Table 4.3: Large Clinical Laboratory Analyzers
    • Table 4.4: Mid-size Clinical Laboratory Analyzers
    • Table 4.5: Small Clinical Laboratory Analyzers
    • Table 4.6: Large Immunochemistry Analyzers
    • Table 4.7: Small Immunoassay Analyzers
    • Table 4.8: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
    • Table 4.9: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
    • Table 4.10: Linearity and Precision of Siemens Hematology Analyzers
    • Table 4.11: Accuracy of the Automated Differential of Siemens Hematology Analyzers
    • Table 4.12: Linearity and Precision of Beckman Coulter Hematology Instruments
    • Table 4.13: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
    • Table 4.14: Linearity and Precision of Horiba ABX Hematology Analyzers
    • Table 4.15: Accuracy of the Horiba ABX Hematology Analyzers
    • Table 4.16: Linearity and Precision of Sysmex Hematology Analyzers
    • Table 4.17: Accuracy of the Sysmex Hematology Analyzers
    • Table 4.18: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
    • Table 4.19: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
    • Table 4.20: Hematology Analyzers with a Five-Part WBC Differential
    • Table 4.21: Hematology Analyzers with a Three-Part WBC Differential
    • Table 4.22: Point of Care Testing
    • Table 4.23: Number of ER Visits in U.S. Hospitals, 1997-2007
    • Table 4.24: Number of POCT in U.S., 2000-2012
    • Table 4.25: PAP Tests in Top European Markets
    • Table 4.26: PAP Tests in Top Asian Markets
    • Table 4.27: Drugs of Abuse Testing Market for POCT Worldwide, 2006-2015
    • Table 4.28: U.S. Point of Care Drugs of Abuse Testing Market, 2006-2015
    • Table 5.1: Normal Glucose Values-Fasting State
    • Table 5.2: Applications for Wireless LAN Technology
    • Table 6:1: Products Marketed by Abbott in the Diagnostics Market
    • Table 7.1: Abaxis Blood Analysis Diagnostic Tests
    • Table 7.2: Reagent Discs Offered with the Piccolo Chemistry Analyzers
    • Table 7.3: Comparison of JEOL Analyzers
    • Table 7.4: The VITROS ECiQ Immunodiagnostic System
    • Table 7.5: Sysmex Marketing Summary for China